Welcome to your Daily Dose of Health Tech Innovation!Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.We bring you expert-curated insights,
Company also provides regulatory update on comparator for OST-HER2 Phase 2b Trial in the Prevention or Delay of Recurrence in Fully Resected, Lung Metastatic Osteosarcoma
OS Therapies Inc., a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, has selected EVERSANA, a leading provider of global commercial services to the life
Company now listeria-based cancer immunotherapy world leader OS Therapies , a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced that it has
OS Therapies, a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, announced it has entered into an asset purchase agreement to
OS Therapies, a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, has partnered with B2i Digital to enhance investor outreach. B2i Digital will
Fuel up with free Health Tech Insights
